title: FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition.
abstract: The existence of microvascular invasion (MVI) formation is one of the most important risk factors predicting poor outcome in hepatocellular carcinoma (HCC) and its mechanism remains largely unknown. Epithelial-Mesenchymal Transition (EMT) has been suggested to be involved in many steps of the invasion-metastasis cascade. To elucidate the possible contribution of EMT to MVI, we initially evaluated the expression of 8 EMT-related transcription factors (TFs) in HCC patients with or without MVI and found that FOXC1 expression was significantly higher in patients with MVI than those without MVI (P < 0.05). Knockdown of FOXC1 expression in HCC cells resulted in a partial conversion of their EMT progresses, mainly regulating the mesenchymal component. Ectopic expression of snail, twist or TGF-β1 could induce expression of FOXC1, but none of the expression of snail, twist, slug or TGF-β was consistently down-regulated in response to FOXC1 silencing, suggesting FOXC1 might operate the downstream of other EMT regulators. In addition, knockdown of FOXC1 expression led to cytoskeleton modification accompanied by decreased ability of cell proliferation, migration, and invasion. Meanwhile, some matrix metalloproteinases (MMPs) and VEGF-A were also simultaneously down-regulated. Together, our findings demonstrate that FOXC1 is one of candidate predictive markers of MVI, and that inhibition of FOXC1 expression can partially reverse EMT program, offering a potential molecular therapeutic target for reducing tumor metastasis in HCC patients.
authors.affiliation: Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Zhejiang Province; Hangzhou, Zhejiang, China.
authors.forename: Zhi-Yuan
authors.initials: ZY
authors.lastname: Xu
authors.forename: Song-Ming
authors.initials: SM
authors.lastname: Ding
authors.forename: Lin
authors.initials: L
authors.lastname: Zhou
authors.forename: Hai-Yang
authors.initials: HY
authors.lastname: Xie
authors.forename: Kang-Jie
authors.initials: KJ
authors.lastname: Chen
authors.forename: Wu
authors.initials: W
authors.lastname: Zhang
authors.forename: Chun-Yan
authors.initials: CY
authors.lastname: Xing
authors.forename: Hai-Jun
authors.initials: HJ
authors.lastname: Guo
authors.forename: Shu-Sen
authors.initials: SS
authors.lastname: Zheng
mesh_terms: D000328:Adult; D000368:Aged; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000098:blood supply*; D003114:Colony-Forming Units Assay; D058750:Epithelial-Mesenchymal Transition / Q000502:physiology*; D005260:Female; D005434:Flow Cytometry; D019084:Fluorescent Antibody Technique, Indirect; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply*; D008297:Male; D055806:Microvessels / Q000254:growth & development*; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: C112743:FOXC1 protein, human; D051858:Forkhead Transcription Factors; D014157:Transcription Factors